Andere talen Suven Pharmaceuticals Limited Bombay S.E.

Aandelen

SUVENPHAR

INE03QK01018

Beurs gesloten - Bombay S.E. Andere beurzen 12:00:53 04-07-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
814,9 ^INR	-1,45%		+3,82%	+12,22%

19/06	Transcript : Sapala Organics Private Limited, Suven Pharmaceuticals Limited - M&A Call
14/06	Suven Pharmaceuticals neemt 67,5% belang in Sapala Organics	MT

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Suven Pharmaceuticals to Acquire 67.5% Stake in Sapala Organics	14/06
Suven Pharmaceuticals Limited agreed to acquire 67.50% stake in Sapala Organics Private Limited for INR 2.3 billion.	13/06
Suven Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	30/05
Suven Pharmaceuticals Limited Announces Shifting of Registered Office	27/03
Indian shares set to rise on strong domestic growth, in-line US inflation data	01/03
Suven Pharmaceuticals Limited agreed to acquire Cohance Lifesciences Limited for INR 81,340.421103 million	29/02
US FDA Clears Suven Pharmaceuticals' API and Formulations Plants in Hyderabad, India	23/02
Suven Pharmaceuticals' Consolidated Net Profit Declines in Fiscal Q3	06/02
Suven Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	05/02
Suven Pharmaceuticals CFO Steps Down	26/12
Suven Pharmaceuticals Limited Announces CFO Changes, Effective January 2, 2024	22/12
Suven Pharmaceuticals Names CFO	22/12
Suven Pharmaceuticals Limited Appoints Dr. Vetukuri Venkata Naga Kali Vara Prasada Raju as Managing Director	15/12
Suven Pharmaceuticals Limited Announces Board Appointments	15/12
Suven Pharmaceuticals Limited Approves Interim Dividend for the Financial Year 2023-24	15/12
Suven Pharmaceuticals Limited Proposes Interim Dividend for the Financial Year 2022-23	22/11
Suven Pharmaceuticals Posts Gains in Fiscal Q2 Consolidated Profit	14/11
Suven Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	09/11
Berhyanda Limited completed the acquisition of 0.001% stake in Suven Pharmaceuticals Limited for INR 1.3 million.	03/11
Suven Pharmaceuticals Limited Announces Board Changes	29-09-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Suven Pharmaceuticals Limited Bombay S.E.

Aandelen

SUVENPHAR

INE03QK01018

Andere talen

Filters